Aldosterone Immunoassay-Specific Cutoff Value for Seated Saline Suppression Test for Diagnosing Primary Aldosteronism

다국어 초록 (Multilingual Abstract)

A seated saline loading test (SLT) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) is one of the most accepted confirmatory tests of primary aldosteronism. However, LC-MS/MS is time-consuming and is not widely available in diagnostic laboratories compared to immunoassay. With immunoassay, it is unknown whether SLT in the seated position is more accurate than that of the supine position, and a cutoff value of post-seated SLT plasma aldosterone concentration (PAC) must be established in the Korean population. Ninety-eight patients underwent SLT in both positions, and post-SLT PAC was measured by LC-MS/MS and radioimmunoassay. We confirmed primary aldosteronism if post-seated SLT PAC by LC-MS/MS exceeded 5.8 ng/dL. The area under the receiver operating characteristic curve was greater for seated than supine SLT (0.928 vs. 0.834, P=0.003). The optimal cutoff value of post-seated SLT by radioimmunoassay was 6.6 ng/dL (sensitivity 83.3%, specificity 92.2%).

참고문헌 (Reference)

1 Eisenhofer G, "The saline infusion test for primary aldosteronism : implications of immunoassay inaccuracy" 107 : e2027-e2036, 2022

2 Funder JW, "The management of primary aldosteronism : case detection, diagnosis, and treatment : an Endocrine Society Clinical Practice Guideline" 101 : 1889-1916, 2016

3 Kayser SC, "Study heterogeneity and estimation of prevalence of primary aldosteronism : a systematic review and meta-regression analysis" 101 : 2826-2835, 2016

4 Monticone S, "Renal damage in primary aldosteronism : a systematic review and meta-analysis" 38 : 3-12, 2020

5 Keevil BG, "Novel liquid chromatography tandem mass spectrometry(LC-MS/MS)methods for measuring steroids" 27 : 663-674, 2013

6 Taylor PJ, "Measurement of aldosterone in human plasma by semiautomated HPLC-tandem mass spectrometry" 55 : 1155-1162, 2009

7 Catena C, "Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism" 50 : 911-918, 2007

8 Hartmann I, "Hypertension outcomes of adrenalectomy for unilateral primary aldosteronism" 76 : 142-150, 2022

9 Ray JA, "Enhancement of specificity of aldosterone measurement in human serum and plasma using 2D-LC-MS/MS and comparison with commercial immunoassays" 970 : 102-107, 2014

10 Burrello J, "Diagnostic accuracy of aldosterone and renin measurement by chemiluminescent immunoassay and radioimmunoassay in primary aldosteronism" 34 : 920-927, 2016

11 Thuzar M, "Diagnosis of primary aldosteronism by seated saline suppression test-variability between immunoassay and HPLC-MS/MS" 105 : dgz150-, 2020

12 Stowasser M, "Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism" 103 : 4113-4124, 2018

13 Manolopoulou J, "Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays" 33 : 2500-2511, 2015

14 Wu X, "Cardiovascular risk in primary aldosteronism: a systematic review and meta-analysis" 98 : e15985-, 2019

15 Guo Z, "Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism" 103 : 3965-3973, 2018